ABT logo

ABT
Abbott Laboratories

17,480
Mkt Cap
$174.69B
Volume
11.94M
52W High
$139.06
52W Low
$99.34
PE Ratio
26.98
ABT Fundamentals
Price
$100.30
Prev Close
$102.72
Open
$102.71
50D MA
$108.92
Beta
0.27
Avg. Volume
12.34M
EPS (Annual)
$3.72
P/B
3.34
Rev/Employee
$385,460.87
$224,844.92
Loading...
Loading...
News
all
press releases
Pharmaceutical Stocks To Research - April 11th
Eli Lilly and Company, Abbott Laboratories, AbbVie, Pfizer, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Medical Stocks To Watch Now - April 11th
Hologic, Eli Lilly and Company, Johnson & Johnson, UnitedHealth Group, and Abbott Laboratories are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical...
MarketBeat·12h ago
News Placeholder
Massachusetts Financial Services Co. MA Sells 577,561 Shares of Abbott Laboratories $ABT
Massachusetts Financial Services Co. MA lessened its position in Abbott Laboratories (NYSE:ABT - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,519,346 shares of the healthcare product maker...
MarketBeat·19h ago
News Placeholder
Bartlett & CO. Wealth Management LLC Decreases Stock Holdings in Abbott Laboratories $ABT
Bartlett & CO. Wealth Management LLC cut its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,011,054 shares of the healthcare product ma...
MarketBeat·23h ago
News Placeholder
Pharmaceutical Stocks To Follow Today - April 10th
Eli Lilly and Company, Abbott Laboratories, Pfizer, AbbVie, Novo Nordisk A/S, Organon & Co., and Zentalis Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...
MarketBeat·2d ago
News Placeholder
Abbott (ABT) Reports Next Week: Wall Street Expects Earnings Growth
Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3d ago
News Placeholder
Abbott Laboratories $ABT Shares Purchased by Willis Investment Counsel
Willis Investment Counsel lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 86.4% during the 4th quarter, according to the company in its most recent filing with the Securities...
MarketBeat·3d ago
News Placeholder
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health New survey finds most Americans believe chronic diseases are...
PR Newswire·3d ago
News Placeholder
Abbott Laboratories $ABT Holdings Boosted by Prime Capital Investment Advisors LLC
Prime Capital Investment Advisors LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 272.4% during the fourth quarter, according to its most recent Form 13F filing with the...
MarketBeat·3d ago
News Placeholder
14,735 Shares in Abbott Laboratories $ABT Acquired by Runnymede Capital Advisors Inc.
Runnymede Capital Advisors Inc. purchased a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the...
MarketBeat·3d ago
<
1
2
...
>

Latest ABT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.